A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine(®) , a high-purity factor IX concentrate, in patients with severe haemophilia B.

Source:http://linkedlifedata.com/resource/pubmed/id/21299747

Download in:

View as

General Info

PMID
21299747